Keila Szpaller writing for the Missoulian, reports that the University of Missoula disease treatment center received $22.4 million from the National Institutes for Health. Teams at the University of Missoula set up the Center for Translational Medicine. This was set up after global pharmaceutical giant GlaxoSmithKline announced a move out of the state. The translational medicine center team, valuing the incredible quality of life the State of Montana has to offer, negotiated contracts with the University of Montana. Read Ms. Szpaller’s article for the details.